HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Punnee Butthep Selected Research

Vasodilator Agents (Vasodilators)

1/2009Altered vascular homeostasis in type 2 diabetic nephropathy.
1/2006Microvascular disease and endothelial dysfunction in chronic kidney diseases: therapeutic implication.
1/2006Early detection of endothelial injury and dysfunction in conjunction with correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy.
1/2004Ganoderma lucidum suppresses endothelial cell cytotoxicity and proteinuria in persistent proteinuric focal segmental glomerulosclerosis (FSGS) nephrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Punnee Butthep Research Topics

Disease

4Dengue Hemorrhagic Fever
01/2015 - 10/2006
4Thalassemia
01/2015 - 06/2002
4Dengue (Dengue Fever)
01/2015 - 10/2006
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2009 - 01/2006
2Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2005 - 01/2004
2beta-Thalassemia (Cooley's Anemia)
01/2004 - 06/2002
1Anoxia (Hypoxia)
02/2015
1Hemoglobinopathies
01/2015
1Anemia
01/2012
1Infection
12/2009
1Vascular System Injuries
01/2008
1Kidney Diseases (Kidney Disease)
01/2006
1Nephrosis
01/2005
1Proteinuria
01/2004
1Neoplasms (Cancer)
01/2003
1Necrosis
01/2003
1alpha-Thalassemia
06/2002

Drug/Important Bio-Agent (IBA)

4Vasodilator Agents (Vasodilators)IBA
01/2009 - 01/2004
3Hemoglobins (Hemoglobin)IBA
02/2015 - 07/2011
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 06/2002
3Hemoglobin EIBA
01/2011 - 06/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2008 - 01/2005
2Hemoglobin Constant SpringIBA
01/2015 - 06/2002
2CytokinesIBA
01/2015 - 12/2012
2Viral AntigensIBA
01/2015 - 12/2009
2Biological Markers (Surrogate Marker)IBA
01/2006 - 01/2005
2Transforming Growth Factor beta (TGF-beta)IBA
01/2006 - 01/2005
1InterleukinsIBA
01/2015
1DNA (Deoxyribonucleic Acid)IBA
01/2015
1ChemokinesIBA
12/2012
1hemoglobin Bart'sIBA
07/2011
1GlobinsIBA
07/2011
1Immunoglobulin G (IgG)IBA
12/2009
1AntigensIBA
12/2009
1isothiocyanic acidIBA
12/2009
1Immunoglobulin M (IgM)IBA
12/2009
1Fluorescein (Funduscein)FDA LinkGeneric
12/2009
1Angiopoietin-2IBA
01/2009
1Angiopoietin-1IBA
01/2009
1EndostatinsIBA
01/2008
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2008
1ThrombomodulinIBA
10/2006
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2006
1Prednisolone (Predate)FDA LinkGeneric
01/2004
1Calcium Channels (Calcium Channel)IBA
01/2004
1von Willebrand FactorIBA
01/2004
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2004
1Interleukin-10 (Interleukin 10)IBA
01/2003
1Protein CIBA
06/2002
1Protein SIBA
06/2002
1Endothelial Growth FactorsIBA
06/2002

Therapy/Procedure

1Blood Transfusion (Blood Transfusions)
01/2012